The White House is working on an executive order aimed at ensuring the US government gets the lowest prescription drug prices given to other countries by invoking a “favored nations clause,” President Trump told reporters 5 July.
The surprise announcement comes about two weeks after the Health and Human Services Department forwarded a proposed rule implementing an International Pricing Index (IPI) model for Medicare Part B drugs to the Office of Management and Budget for pre-release review. The IPI includes an international reference pricing component that seems similar in concept to what Trump was talking about
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?